Stock Financial Ratios

CVSI / CV Sciences, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Market Cap ($M)18.96
Enterprise Value ($M)29.83
Book Value ($M)13.21
Book Value / Share0.25
Price / Book1.44
NCAV ($M)14.66
NCAV / Share0.28
Price / NCAV-49.21
Income Statement (mra) ($M)
Net Income-14.14
Balance Sheet (mrq) ($M)
Cash & Equivalents0.00
Cash / Share0.00
Quick Ratio0.38
Current Ratio1.28
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-1.07
Return on Assets (ROA)-0.79
Return on Equity (ROE)-1.07
Identifiers and Descriptors
Central Index Key (CIK)1510964
Industry Groups
SIC 512227 - Cannabis and Medical Marijuana Dispensaries
Share Statistics
Common Shares Outstanding (M)90.51
Scoring Models
Piotroski F Score4.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Goodwill Per Share0.05
Property Plant And Equipment Gross Per Share0.01
Assets Current Per Share0.09
Cash And Equivalents Per Share0.00
Liabilities Other Non Current Per Share0.00
Intangibles Per Share0.00
Accounts Receivable Per Share0.02
Minority Interest Per Share0.00
Liabilities And Stock Equity Per Share0.39
Current Portion Of Long Term Debt Per Share0.00
Deferred Income Tax Liabilities Per Share0.03
Property Plant And Equipment Per Share0.00
Long Term Debt Per Share0.00
Assets Other Current Per Share0.00
Cash Per Share0.00
Inventory Per Share0.06
Accounts Payable Per Share0.00
Liabilities Per Share0.10
Assets Non Current Per Share0.00
Preferred Stock Value Outstanding Per Share0.00
Assets Other Non Current Per Share0.01
Inventory Work In Progress Per Share0.00
Retained Earnings Per Share-0.67
Additional Paid In Capital Per Share0.96
Property Plant And Equipment Net Per Share0.00
Equity Per Share0.29
Treasury Stock Per Share0.00
Accumulated Depreciation And Depletion Per Share0.01
Liabilities Current Per Share0.07
Assets Per Share0.31
Debt Per Share0.00
Inventory Finished Goods Per Share0.03
Inventory Raw Materials Per Share0.13

Stock Research Report

CV Sciences was incorporated under the name Foreclosure Solutions, Inc. in the State of Texas on December 9, 2010. On July 25, 2013, the Company’s predecessor, CannaVest Corp., a Texas corporation (“CannaVest Texas”), merged with the Company, a wholly-owned Delaware subsidiary of CannaVest Texas, to effectuate a change in the Company’s state of incorporation from Texas to Delaware. On January 4, 2016, the Company filed a Certificate of Amendment of Certificate of Incorporation with the Secretary of State of the State of Delaware, reflecting its corporate name change to “CV Sciences, Inc.”, effective on January 5, 2016. In addition, on January 4, 2016, the Company amended its Bylaws to reflect its corporate name change to “CV Sciences, Inc.” The Company previously operated under the corporate name of CannaVest Corp. On June 8, 2016, the Company changed its trading symbol from CANV to CVSI, and continues to be traded on the OTC: QB.

The change in corporate name was undertaken in conn...

Click for full article

Related News Stories

Top-Performing Marijuana Stocks Of December

2017-12-28 seekingalpha
December has seen the culmination of at least 2 distinct catalysts propel several leading marijuana stocks much higher before the end of the year. (48-0)

CV Sciences, Inc. 2017 Q3 - Results - Earnings Call Slides

2017-11-10 seekingalpha
The following slide deck was published by CV Sciences, Inc. in conjunction with their 2017 Q3 earnings call. (3-1)

CV Sciences' (CVSI) Management on Q3 2017 Results - Earnings Call Transcript

2017-11-09 seekingalpha
Greetings and welcome to CV Sciences’ 2017 Third Quarter Conference Call. At this time all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] Remind you that this conference is being recorded. (9-0)

CV Sciences Takes Aim at Smokeless Tobacco Addiction with CBD-Based Therapy

2017-10-17 accesswire
SANTA MONICA, CA / ACCESSWIRE / October 17, 2017 / According to the Centers for Disease Control and Prevention, tobacco use causes almost six million deaths annually, with that number expected to climb to eight million by 2030 based on current trends. In the U.S. alone, about one in five deaths, or approximately 1,300 deaths every day, are the result of cigarette smoking, making it a leading cause of preventable death. (3-1)

CUSIP: 126654102